Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Goodwill & Intangibles (2020 - 2022)

Historic Goodwill & Intangibles for Ovid Therapeutics (OVID) over the last 3 years, with Q1 2022 value amounting to $244000.0.

  • Ovid Therapeutics' Goodwill & Intangibles fell 722.43% to $244000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $244000.0, marking a year-over-year decrease of 722.43%. This contributed to the annual value of $263000.0 for FY2021, which is 1755.49% down from last year.
  • Per Ovid Therapeutics' latest filing, its Goodwill & Intangibles stood at $244000.0 for Q1 2022, which was down 722.43% from $263000.0 recorded in Q4 2021.
  • In the past 5 years, Ovid Therapeutics' Goodwill & Intangibles ranged from a high of $436000.0 in Q1 2020 and a low of $197000.0 during Q3 2021
  • For the 3-year period, Ovid Therapeutics' Goodwill & Intangibles averaged around $290625.0, with its median value being $263000.0 (2021).
  • Per our database at Business Quant, Ovid Therapeutics' Goodwill & Intangibles plummeted by 3967.89% in 2021 and then crashed by 722.43% in 2022.
  • Over the past 3 years, Ovid Therapeutics' Goodwill & Intangibles (Quarter) stood at $319000.0 in 2020, then fell by 17.55% to $263000.0 in 2021, then decreased by 7.22% to $244000.0 in 2022.
  • Its last three reported values are $244000.0 in Q1 2022, $263000.0 for Q4 2021, and $197000.0 during Q3 2021.